Emergence and spread of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus in Belgian hospitals

Microbial Drug Resistance

Volumn 9, Issue 1, 2003, Pages 61-71

  Denis, Olivier ^a   Deplano, Ariane ^a   De Ryck, Raf ^a   Nonhoff, Claire ^a   Struelens, Marc J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; MINOCYCLINE; NETILMICIN; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; TROVAFLOXACIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BELGIUM; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0037357142     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662903764736355     Document Type: Article

References (49)

1. Aires de Sousa, M., M. Miragaia, I. Santos Sanches, S. Avila, I. Adamson, S.T. Casagrande, M.C.C. Brandileone, R. Palacio, L. Dell'Acqua, M. Hortal, T. Camou, A. Rossi, M.E. Velazquez-Meza, G. Echaniz-Aviles, F. Solorzano-Santos, I. Heitmann, and H. de Lencastre. 2001. Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J. Clin. Microbiol. 39:2197-2205.
2. Ariza, J., M. Pujol, J. Cabo, C. Pena, N. Fernandez, J. Linares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353:1587-1588.
3. Aubry-Damon, H., P. Legrand, C. Brun-Buisson, A. Astier, C.J. Soussy, and R. Leclercq. 1997. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin. Infect. Dis. 25:647-653.
4. Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H.G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18:691-696.
5. Blanc, D.S., A.L. Banuls, P.M. Hauser, P. Moreillon, P. Francioli, and M. Tibayrenc. 2000. Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains. Microb. Drug Resist. 6:231-238.
6. Blanc, D.S., P. Francioli, A. Le Coustumier, L. Gazagne, E. Lecaillon, P. Gueudet, F. Vandenesch, and J. Etienne. 2001. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus in France: a phylogenetic approach. J. Clin. Microbiol. 39:2287-2290.
7. CDC NNIS System. 1999. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27:520-532.
8. Chesneau, O., A. Morvan, and N. El Solh. 2000. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J. Antimicrob. Chemother. 45:887-890.
9. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1996. Zone sizes and MIC breakpoints for non fastidious organisms. Clin. Microbiol. Infect. 2(Suppl. 1):S1-S49.
10. Cookson, B.D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41:11-18.
11. Denis, O., M.J. Struelens, and B. Jans. 1999. Improvement of methicillin susceptibility testing methods for Staphylococcus aureus in Belgian hospitals: 1991-1997. 9th European Congress of Clinical Microbiology and Infectious Diseases. Berlin, Germany. Abstract, paper P124.
12. Denis, O., C. Nonhoff, S. Bobin-Dubreux, B. Byl, C. Knoop, and M.J. Struelens. 2002. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian Hospital: microbiological and clinical features. J. Antimicrob. Chemother. 50:383-391.
13. Deplano, A., W. Witte, W.J. van Leeuwen, Y. Brun, and M.J. Struelens. 2000. Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries. Clin. Microbiol. Infect. 6:239-245.
14. Deplano, A., M. Vaneechoutte, G. Verschraegen, and M.J. Struelens. 1997. Typing of Staphylococcus aureus and Staphylococcus epidermidis strains by PCR analysis of inter-IS256 spacer length polymorphisms. J. Clin. Microbiol. 35:2580-2587.
15. Deplano, A., A. Schuermans, J. Van Eldere, W. Witte, H. Meugnier, J. Etienne, H. Grundmann, D. Jonas, G.T. Noordhoek, J. Dijkstra, A. van Belkum, W. van Leeuwen, P.T. Tassios, N.J. Legakis, A. van der Zee, A. Bergmans, D.S. Blanc, F.C. Tenover, B.C. Cookson, G. O'Neil, and M.J. Struelens. 2000. Multicenter evaluation of epidemiological typing of methicillin-resistant Staphylococcus aureus strains by repetitive -element PCR analysis. J. Clin. Microbiol. 38:3527-3533.
16. Deplano, A., A. Zekhnini, N. Allali, M. Couturier, and M.J. Struelens. 1997. Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 41:2023-2025.
17. Enright, M.C., N.P.J. Day, C.E. Davies, S.J. Peacock, and B.G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
18. Enright, M.C., D.A. Robinson, G. Randle, E.J. Feil, H. Grundmann, and B.G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. 99:7687-7692.
19. Galdbart, J.O., A. Morvan, and N. El Solh. 2000. Phenotypic and molecular typing of nosocomial methicillin-resistant Staphylococcus aureus strains susceptible to gentamicin isolated in France from 1995 to 1997. J. Clin. Microbiol. 38:185-190.
20. Geisel, R., F.J. Schmitz, L. Thomas, G. Berns, O. Zetsche, B. Ulrich, A.C. Fluit, H. Labischinsky, and W. Witte. 1999. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J. Antimicrob. Chemother. 43:846-848.
21. Guerin, F., A. Buu-Hoi, J.L. Mainardi, G. Kac, N. Colardelle, S. Vaupre, L. Gutmann, and I. Podglajen. 2000. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J. Clin. Microbiol. 38:2985-2988.
22. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
23. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:486-493.
24. Ida, T., R. Okamoto, C. Shimauchi, T. Okubo, A. Kuga, and M. Inoue. 2001. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J. Clin. Microbiol. 39:3115-3121.
25. Ito, T., Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336.
26. Kantzanou, M., P.T. Tassios, A. Tseleni-Kotsovili, N.J. Legakis, and A.C. Vatopoulos. 1999. Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 43:729-731.
27. Kim, M.N., S.H. Hwang, Y.J. Pyo, H.M. Mun, and C.H. Pai. 2002. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J. Clin. Microbiol. 40:1376-1380.
28. Laurent, F., H. Lelievre, M. Cornu, F. Vandenesch, G. Carret, J. Etienne, and J.P. Flandrois. 2001. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J. Antimicrob. Chemother. 47:277-283.
29. Lelievre, H., G. Lina, M.E. Jones, C. Olive, F. Forey, M. Roussel-Delvallez, M.H. Nicolas-Chanoine, C.M. Bébéar, V. Jarlier, A. Andremont, F. Vandenesch, and J. Etienne. 1999. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J. Clin. Microbiol. 37:3452-3457.
30. Leski, T., D. Oliveira, K. Trzcinski, I. Santos Sanches, M. Aires de Sousa, W. Hryniewicz, and H. de Lencastre. 1998. Clonal distribution of methicillin-resistant Staphylococcus aureus in Poland. J. Clin. Microbiol. 36:3532-3539.
31. Leski, T.A., M. Gniadkowski, A. Skoczynska, E. Stefaniuk, K. Trzcinski, and W. Hryniewicz. 1999. Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J. Clin. Microbiol. 37:2781-2788.
32. National Committee for Clinical Laboratory Standard. 2001. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved Standard M7-A4. National Committee for Clinical Laboratory Standard, Villanova, PA.
33. Oliveira, D.C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.
34. Ramsey, M.A., S.F. Bradley, C.A. Kauffman, and T.M. Morton. 1996. Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob. Agents Chemother. 40:2820-2823.
35. Roberts, R.B., M. Chung, H. de Lencastre, J. Hargrave, A. Tomasz, D.P. Nicolau, J.F. John, Jr., and O. Korzeniowski. 2000. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. Microb. Drug Resist. 6:245-251.
36. Schmitz, F.J., E. Lindenlauf, B. Hofmann, A.C. Fluit, J. Verhoef, H.P. Heinz, and M.E. Jones. 1998. The prevalence of low-and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 42:489-495.
37. Sieradzki, K., R.B. Roberts, S.W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
38. Smith, T.L., M.L. Pearson, K.R. Wilcox, C. Cruz, M.V. Lancaster, B. Robinson-Dunn, F.C. Tenover, M.J. Zervos, J.D. Band, E. White, and W.R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340:493-501.
39. Struelens, M.J., O. Ronveaux, B. Jans, and R. Mertens. 1996. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Infect. Control Hosp. Epidemiol. 17:503-508.
40. Struelens, M.J., and R. Mertens. 1994. National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. Eur. J. Clin. Microbiol. Infect. Dis. 13:56-63.
41. Struelens, M.J., A. Deplano, C. Godard, N. Maes, and E. Serruys. 1992. Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. J. Clin. Microbiol. 30:2599-2605.
42. Tenover, F.C., M.V. Lancaster, B.C. Hill, C.D. Steward, S.A. Stocker, G.A. Hancock, C.M. O'Hara, N.C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
43. The Groupement pour le Dépistage l'Étude et la Prévention des Infections Hospitalières-Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH.GOSPIZ). 1994. Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Acta Clin. Belg. 49:108-113.
44. Van der Auwera, P., C. Godard, C. Denis, S. De Maeyer, and R. Vanhoof. 1990. In vitro activities of new antimicrobial agents against multi-resistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrob. Agents Chemother. 34:2260-2262.
45. Vasquez, J.E., E.S. Walker, B.W. Franzus, B.K. Overbay, D.R. Reagan, and F.A. Sarubbi. 2000. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect. Control Hosp. Epidemiol. 21:459-464.
46. Voss, A., D. Milatovic, C. Wallrauch-Schwarz, V.T. Rosdahl, and I. Braveny. 1994. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:50-55.
47. Walsh, T.R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R.A. Howe, A.P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
48. Wildemauwe, C., C. Godard, R. Vanhoof, E. Van Bossuyt, and E. Hannecart-Pokorni. 1996. Changes in major populations of methicillin-resistant Staphylococcus aureus in Belgium. J. Hosp. Infect. 34:197-203.
49. Woodford, N., M. Warner, and H.M. Aucken. 2000. Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and Wales. J. Antimicrob. Chemother. 45:258-259.